Literature DB >> 30566412

Potential retinal biomarkers for dementia: what is new?

Carol Y Cheung1, Victor T T Chan1, Vincent C Mok2, Christopher Chen3,4, Tien Y Wong5,6.   

Abstract

PURPOSE OF REVIEW: To summarize the current findings on clinical retinal diseases and retinal imaging changes with dementia, focusing on Alzheimer's disease. RECENT
FINDINGS: Studies observed that clinical retinal diseases such as age-related macular degeneration, open-angle glaucoma and diabetic retinopathy are related to dementia, but the associations are not entirely consistent. In terms of the retinal neuronal structure, multiple retinal neuronal layers are significantly thinner in Alzheimer's disease dementia, such as the parapapillary retinal nerve fiber layer (RNFL) and macular ganglion cell-inner plexiform layer (GC-IPL). Recent studies further demonstrated that macular GC-IPL and macular RNFL are also significantly thinner in the preclinical stage of Alzheimer's disease. A thinner RNFL is also associated with a significantly increased risk of developing both cognitive decline and Alzheimer's disease dementia. In addition, studies consistently showed that retinal vascular changes are associated with poorer cognitive performance, as well as prevalent and incident Alzheimer's disease dementia.
SUMMARY: The current findings support the concept that changes in the retina, particular in retinal neuronal structure and vasculature, can reflect the status of cerebral neuronal structure and vasculature, highlighting the potential role of retinal changes as biomarkers of dementia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30566412     DOI: 10.1097/WCO.0000000000000645

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  12 in total

1.  Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study.

Authors:  Phillip H Hwang; Will T Longstreth; Stephen M Thielke; Courtney E Francis; Marco Carone; Lewis H Kuller; Annette L Fitzpatrick
Journal:  Alzheimers Dement       Date:  2021-03-31       Impact factor: 21.566

Review 2.  The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis.

Authors:  Robert N F Chan; Ziqi Tang; Victor T T Chan; Raymond N C Chan; Esther T W Cheng; Natalie C Y Ng; Carol Y Cheung
Journal:  Eye (Lond)       Date:  2022-05-02       Impact factor: 3.775

3.  Deep-learning retinal vessel calibre measurements and risk of cognitive decline and dementia.

Authors:  Carol Y Cheung; Win Lee Edwin Wong; Saima Hilal; Cheuk Ni Kan; Bibek Gyanwali; Yih Chung Tham; Leopold Schmetterer; Dejiang Xu; Mong Li Lee; Wynne Hsu; Narayanaswamy Venketasubramanian; Boon Yeow Tan; Tien Yin Wong; Christopher P L H Chen
Journal:  Brain Commun       Date:  2022-08-17

4.  Retinal Microvascular Caliber and Incident Depressive Symptoms: The Multi-Ethnic Study of Atherosclerosis.

Authors:  April C E van Gennip; Sanaz Sedaghat; Mercedes R Carnethon; Norrina B Allen; Barbara E K Klein; Mary Frances Cotch; Diana A Chirinos; Coen D A Stehouwer; Thomas T van Sloten
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

5.  Retinal Microvascular Alterations as the Biomarkers for Alzheimer Disease: Are We There Yet?

Authors:  Hong Jiang; Jianhua Wang; Bonnie E Levin; Bernard S Baumel; Christian J Camargo; Joseph F Signorile; Tania Rundek
Journal:  J Neuroophthalmol       Date:  2021-06-01       Impact factor: 4.415

Review 6.  Insights into Systemic Disease through Retinal Imaging-Based Oculomics.

Authors:  Siegfried K Wagner; Dun Jack Fu; Livia Faes; Xiaoxuan Liu; Josef Huemer; Hagar Khalid; Daniel Ferraz; Edward Korot; Christopher Kelly; Konstantinos Balaskas; Alastair K Denniston; Pearse A Keane
Journal:  Transl Vis Sci Technol       Date:  2020-02-12       Impact factor: 3.283

7.  Retinal Imaging Techniques Based on Machine Learning Models in Recognition and Prediction of Mild Cognitive Impairment.

Authors:  Qian Zhang; Jun Li; Minjie Bian; Qin He; Yuxian Shen; Yue Lan; Dongfeng Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-11-06       Impact factor: 2.570

Review 8.  Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.

Authors:  Stela Vujosevic; M Margarita Parra; M Elizabeth Hartnett; Louise O'Toole; Alessia Nuzzi; Celeste Limoli; Edoardo Villani; Paolo Nucci
Journal:  Eye (Lond)       Date:  2022-04-15       Impact factor: 4.456

Review 9.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

10.  Visual tests predict dementia risk in Parkinson disease.

Authors:  Louise-Ann Leyland; Fion D Bremner; Ribeya Mahmood; Sam Hewitt; Marion Durteste; Molly R E Cartlidge; Michelle M-M Lai; Luke E Miller; Ayse P Saygin; Pearse A Keane; Anette E Schrag; Rimona S Weil
Journal:  Neurol Clin Pract       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.